We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-15.9%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$314B
AUM Growth
-$33.1B
Cap. Flow
+$31.5B
Cap. Flow %
10.02%
Top 10 Hldgs %
30.1%
Holding
11,456
New
1,843
Increased
4,539
Reduced
3,686
Closed
1,300

Sector Composition

Rank Sector Weight
1 Technology 2.01%
2 Communication Services 1.39%
3 Financials 0.98%
4 Consumer Discretionary 0.94%
5 Healthcare 0.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDNY
9626
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$52K ﹤0.01%
3,806
-8,974
-70% -$106K
OTIC
9627
DELISTED
Otonomy, Inc.
OTIC
$52K ﹤0.01%
26,597
-49,741
-65% -$153K
TYME
9628
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$52K ﹤0.01%
47,537
-4,424
-9% -$5.95K
KDMN
9629
PUT
DELISTED
Kadmon Holdings, Inc.
KDMN
$52K ﹤0.01%
+12,500
New +$53.8K
OESX icon
9630
PUT
Orion Energy Systems
OESX
$102M
$51K ﹤0.01%
+1,390
New +$60.9K
VEON icon
9631
VEON
VEON
$4.16B
$51K ﹤0.01%
1,364
+583
+75% +$32.1K
GPL
9632
DELISTED
Great Panther Mining Limited
GPL
$51K ﹤0.01%
+16,569
New +$83.1K
NE
9633
PUT
DELISTED
Noble Corporation
NE
$51K ﹤0.01%
195,900
-24,100
-11% -$17.9K
ERNA icon
9634
Eterna Therapeutics
ERNA
$5.7M
$50K ﹤0.01%
2
+1
+100% +$30.4K
CBIO
9635
Crescent Biopharma
CBIO
$669M
$50K ﹤0.01%
219
+88
+67% +$33.6K
IPI icon
9636
Intrepid Potash
IPI
$503M
$50K ﹤0.01%
6,283
-1,912
-23% -$35.6K
TGS icon
9637
CALL
Transportadora de Gas del Sur
TGS
$4.27B
$50K ﹤0.01%
10,800
-4,400
-29% -$25.7K
ADMS
9638
DELISTED
Adamas Pharmaceuticals
ADMS
$50K ﹤0.01%
17,276
-45,947
-73% -$206K
ABEV icon
9639
PUT
Ambev
ABEV
$44.7B
$49K ﹤0.01%
21,400
+9,500
+80% +$34.4K
CATX icon
9640
Perspective Therapeutics
CATX
$361M
$49K ﹤0.01%
+9,243
New +$69.8K
CNTY icon
9641
CALL
Century Casinos
CNTY
$35.2M
$49K ﹤0.01%
+20,500
New +$133K
HBIO icon
9642
Harvard Bioscience
HBIO
$34.8M
$49K ﹤0.01%
+2,195
New +$59.5K
KZR
9643
DELISTED
Kezar Life Sciences
KZR
$49K ﹤0.01%
+1,134
New +$46.1K
LXRX icon
9644
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
$49K ﹤0.01%
25,000
-94,900
-79% -$282K
MNOV icon
9645
MediciNova
MNOV
$72.8M
$49K ﹤0.01%
+13,256
New +$69K
WOW
9646
DELISTED
WideOpenWest
WOW
$49K ﹤0.01%
+10,294
New +$62.4K
JXG
9647
JX Luxventure
JXG
$105M
$49K ﹤0.01%
+49
New +$56.7K
STCN
9648
DELISTED
Steel Connect, Inc. Common Stock
STCN
$49K ﹤0.01%
7,061
+790
+13% +$9.91K
BGC icon
9649
CALL
BGC Group
BGC
$5.66B
$48K ﹤0.01%
19,100
-29,000
-60% -$142K
CIF
9650
DELISTED
MFS Intermediate High Income Fund
CIF
$48K ﹤0.01%
+23,058
New +$60.8K

Similar funds

Jeff Yass's Q1 2020 Portfolio in Review

As of Q1 2020, Jeff Yass held 11,456 positions worth $314B, down 9.5% from $347B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass deployed $31.5B of net new capital in Q1 2020, opening 1,843 new positions and adding to 4,539 existing holdings. Its largest new stake was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.

By sector, the portfolio is most concentrated in Technology at 2% of assets, down from 2.2% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Amazon, an estimated $946M trimmed.

  • Jeff Yass's largest Q1 2020 buy was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $6.39B increase.
  • Jeff Yass's biggest Q1 2020 reduction was Amazon, cutting an estimated $946M.
  • Jeff Yass fully exited Medicines Co in Q1 2020, selling an estimated $92M.
  • Jeff Yass's ten largest holdings make up 30% of its $314B portfolio in Q1 2020.
  • Jeff Yass opened 1,843 new positions and closed 1,300 in Q1 2020.
  • Jeff Yass's portfolio value fell 9.5% quarter-over-quarter to $314B.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.